Disclosure: As a BetterHelp affiliate, we receive compensation from BetterHelp if you purchase products or services through the links provided.

Depression is a complex mental health condition that affects millions worldwide, transcending age, gender, and cultural boundaries.

Depression can manifest in various forms, ranging from mild to severe, and can be influenced by genetic, biological, environmental, and psychological factors.

Finding an effective treatment for depression can be a challenging journey. While many individuals respond well to conventional medications, there is a subset of people who grapple with treatment-resistant depression. 

This article aims to explore the different ways depression can manifest, covering the standard medications often used to address depressive symptoms, the unique nature of treatment-resistant depression, and various strategies employed in managing this condition.

Types of Depression

Depression is not a one-size-fits-all diagnosis; it comes in various forms, each with distinct characteristics. Here are some of the most common types:

1. Major Depressive Disorder (MDD): This is what many people think of when they hear the term “depression.”

MDD is characterized by persistent feelings of sadness, hopelessness, and a loss of interest in previously enjoyed activities. It often includes physical symptoms like changes in appetite and sleep patterns.

2. Persistent Depressive Disorder (Dysthymia): This is a milder, but chronic form of depression. People with dysthymia may experience long-term symptoms, often lasting for two years or more. While not as severe as MDD, it can still significantly impact one’s quality of life.

3. Bipolar Disorder: Previously known as manic depression, this condition involves periods of intense, elevated mood (mania) followed by depressive episodes. Bipolar disorder has several subtypes, including Bipolar I and Bipolar II.

4. Seasonal Affective Disorder (SAD): Some individuals experience depressive symptoms that occur seasonally, typically in the fall and winter when there is less sunlight. Exposure to light therapy can be an effective treatment for SAD.

5. Psychotic Depression: People with psychotic depression experience not only depressive symptoms but also hallucinations or delusions.

6. Postpartum Depression: Occurring after childbirth, postpartum depression affects some new mothers and may have a significant impact on maternal and child well-being.

Standard Medications for Depression

medication
Image Credit: medssafety.com

The cornerstone of depression treatment often involves the use of medication. These medications aim to restore the balance of neurotransmitters in the brain, particularly serotonin, norepinephrine, and dopamine, which play key roles in regulating mood. 

The most commonly prescribed medications for depression are:

1. Selective Serotonin Reuptake Inhibitors (SSRIs): 

SSRIs, like Prozac (fluoxetine), Zoloft (sertraline), and Lexapro (escitalopram), are among the most commonly prescribed antidepressants.

They work by increasing the levels of serotonin in the brain, which can improve mood and alleviate symptoms of depression. 

SSRIs are often considered a first-line treatment due to their effectiveness and relatively mild side effects compared to older antidepressants.

2. Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs): 

SNRIs, such as Cymbalta (duloxetine) and Effexor (venlafaxine), target serotonin and norepinephrine reuptake.

This dual mechanism can be beneficial for individuals who don’t respond well to SSRIs alone.

3. Tricyclic Antidepressants (TCAs): 

TCAs, like amitriptyline and imipramine, are older antidepressants. They are used less frequently today due to their more significant side effects, but they can still be effective in cases of TRD where other treatments have failed.

4. Monoamine Oxidase Inhibitors (MAOIs): 

MAOIs, such as Nardil (phenelzine) and Parnate (tranylcypromine), are another older class of antidepressants.

They are reserved for cases where other medications haven’t been effective, as they have strict dietary restrictions and can interact with various other medications.

These standard medications, often prescribed as first-line treatments for depression, can significantly improve symptoms for many individuals.

However, in cases of Treatment-Resistant Depression (TRD), where the standard treatments have proven ineffective, alternative approaches are considered.

Nature of Treatment-Resistant Depression

Treatment-Resistant Depression (TRD), a form of depression that doesn’t respond adequately to standard depression treatments, poses a significant challenge for both patients and mental health professionals. 

TRD is typically defined as a lack of adequate response to two or more courses of antidepressant medications at the maximum tolerated dose and duration.

In simpler terms, it means that despite trying multiple antidepressant medications over a sufficient period, the depressive symptoms persist or return. 

Research studies show that about one-third of depression patients experience TRD. The diagnosis of TRD often involves a thorough assessment by a mental health professional who reviews the patient’s treatment history and evaluates the nature and severity of their depression.

TRD may be associated with specific underlying factors that contribute to its resistance to treatment. These factors can include genetic predisposition, comorbid conditions (such as anxiety disorders), unresolved trauma, or medical conditions. 

TRD can have a severe impact on an individual’s quality of life. The persistent symptoms of depression, along with the frustration of failed treatments, can lead to a sense of hopelessness and despair.

Patients with TRD may struggle with daily functioning, employment, relationships, and overall well-being.

TRD is not just about unrelenting emotional suffering. It can also increase the risk of various complications, including substance abuse, physical health problems, and an elevated risk of self-harm or suicidal thoughts. Therefore, prompt and effective intervention is crucial.

Most Effective Medications for Treatment-Resistant Depression

Medications play a crucial role in the treatment of individuals with treatment-resistant depression (TRD). The most effective options include the following.

1. Esketamine 

Esketamine represents a significant breakthrough in treating treatment-resistant depression. With the FDA’s 2019 approval of this medication under the brand name Spravato, there emerged a renewed sense of optimism for those who hadn’t responded positively to conventional antidepressants. 

Classified as an N-methyl D-aspartate (NMDA) receptor blocker, esketamine finds its origin in ketamine, a dissociative anesthetic historically used in medical and veterinary settings.

Ketamine’s potential as an antidepressant has been studied extensively from 2000 to 2006, suggesting its effectiveness in managing depression.

Esketamine treatment, akin to its predecessor, ketamine, may temporarily alter perception, necessitating administration in a clinical environment.

This nasal spray is typically given on an outpatient basis, with individuals self-administering three doses, spaced five minutes apart, under professional supervision. 

Patients remain in the clinic under observation until any possible side effects have subsided. This medication is meant to complement traditional antidepressants, offering swift relief from depressive symptoms while the other medication takes effect.

Usually, the initial treatment phase involves two sessions weekly for the first month. If successful, the maintenance phase follows, gradually reducing the frequency of doses based on the treatment’s response. 

Typically, this involves a decrease to weekly, bi-weekly, and then monthly treatments.

Currently, esketamine is sanctioned for individuals with treatment-resistant depression, indicating that they’ve undergone at least two other antidepressant treatments (each lasting six weeks) without achieving remission or a 50% mood improvement.

2. Zuranolone

Zuranolone, a collaborative development by Biogen and Sage Therapeutics, is a groundbreaking pharmaceutical that offers a promising approach to depression treatment.

Available in oral capsule form, it has gained FDA approval for a 14-day treatment course specifically designed for adults with postpartum depression (PPD). 

This innovative medication takes a unique approach, targeting inhibitory signaling through the GABA pathway within the brain.

It has earned recognition for its rapid action, with some individuals experiencing an improvement in their condition within two or three days.

A significant advantage of Zuranolone is its short treatment duration, lasting only two weeks, yet its therapeutic effects persist well beyond this timeframe.

This departure from the conventional long-term use of antidepressants not only offers greater convenience but also holds the potential to minimize associated side effects. 

Zuranolone’s remarkable attributes have prompted its evaluation in Phase II for the treatment of Treatment-Resistant Depression (TRD), signifying its potential as a transformative option in the field of mental health therapeutics.

3. Symbyax

Symbyax, crafted by Eli Lilly & Co., is a distinct pharmaceutical blend consisting of two widely successful drugs – Prozac and Zyprexa.

This combination comprises olanzapine, classified as an atypical antipsychotic, and fluoxetine, recognized as a selective serotonin reuptake inhibitor. 

Initially approved by the U.S. Food and Drug Administration to address bipolar depression in 2003, Symbyax gained further approval in 2009 for treating depression unresponsive to other antidepressants.

This specific drug is an alternative for adults with depression who have previously attempted treatment with two other medications but without success.

However, despite its efficacy, Symbyax poses considerable risks. It is associated with a lengthy roster of side effects, including the potential of severe birth defects in pregnant women. 

Given its combination nature, Symbyax carries the possibility of side effects associated with both antipsychotic medications and SSRI antidepressants.

Understanding the benefits and risks is crucial, and this medication is usually considered after other standard treatments have failed.

Other Therapeutic Approaches for Treatment-Resistant Depression

1. Electroconvulsive Therapy (ECT):

ECT is often reserved for individuals facing severe or life-threatening depression that has proven resistant to other interventions.

This treatment method involves administering controlled electrical impulses to induce therapeutic seizures in the brain. 

A typical ECT course consists of 6 to 12 treatments over several weeks. ECT has demonstrated a remarkable ability to swiftly alleviate depressive symptoms.

However, to prevent relapse, ongoing therapy is often necessary, whether it be medication or periodic ECT “booster” sessions.

2. Repetitive Transcranial Magnetic Stimulation (rTMS):

rTMS is a noninvasive approach that employs a magnetic coil to modulate the brain’s natural electrical activity, specifically targeting areas linked to mood regulation.

This therapy can influence and modify the brain’s neural circuitry associated with depression. By utilizing magnetic fields, rTMS aims to provide relief from treatment-resistant depression.

3. Combination and Augmentation Therapy:

For individuals grappling with treatment-resistant depression, a combination of therapies is often considered.

This approach involves adding a second antidepressant from a different class, a strategy known as combination therapy. 

Alternatively, augmentation therapy involves supplementing the treatment regimen with medications not traditionally used for depression, such as antipsychotics or anticonvulsants like lithium. 

Notably, certain drugs, including aripiprazole (Abilify), brexpiprazole (Rexulti), and quetiapine (Seroquel XR), have received FDA approval for use as adjunct therapies alongside antidepressants in cases of treatment-resistant depression.

Support and Guidance with BetterHelp

BetterHelp offers a valuable resource for individuals dealing with depression. Their platform connects users with licensed mental health professionals who can provide guidance and support.

Whether you’re struggling with standard depression or TRD, the convenience of online therapy allows you to access expert help from the comfort of your own space. 

BetterHelp’s experienced therapists can employ evidence-based techniques, personalized treatment plans, and a compassionate approach to help you navigate the challenges of depression.

Through secure and confidential online sessions, you can engage in therapy at your own pace and on your own terms. 

Depression can be isolating, but with BetterHelp, you don’t have to face it alone, and you can take the first step toward healing and recovery.

Conclusion

The treatment of Treatment-Resistant Depression (TRD) can be a complex and challenging journey. However, the existence of effective medications, particularly Esketamine, offers hope for those who have not found relief through standard antidepressants.

Strict adherence to your treatment plan, following your healthcare provider’s guidance, and open communication about your progress are vital components of managing TRD successfully.

While the path may be arduous, it’s essential to stay committed to your well-being and explore the options available to achieve a brighter, more fulfilling future.

FAQ’s:

1. How is treatment-resistant depression diagnosed?

A diagnosis of treatment-resistant depression is typically made after a person has failed to respond adequately to multiple trials of antidepressant medications and other evidence-based treatments.

Healthcare professionals may assess the individual’s treatment history, symptom severity, and response to previous interventions to make this determination.

2. Can lifestyle changes help with treatment-resistant depression?

While lifestyle changes alone may not be sufficient to address treatment-resistant depression, they can play a supportive role in overall treatment.

Engaging in regular physical activity, maintaining a balanced diet, getting sufficient sleep, practicing stress management techniques, and seeking social support can all contribute to improved well-being.

3. Is there hope for individuals with treatment-resistant depression?

Yes, there is hope for individuals with treatment-resistant depression.

With the guidance of qualified healthcare professionals, a comprehensive and individualized treatment plan can be developed, which may involve exploring different medication options, combining treatments, and considering emerging therapies.

nlpa

Categories

Therapists that Understand You!

Find a therapist that fully understands ALL of you. Speaking with someone who has a similar cultural background and view on the world can be very comforting.

Find a Therapist that get YOU!